Screener/Healthcare/Biotechnology

KPTI

Karyopharm Therapeutics Inc.NASDAQ
$5.34-1.31 (-19.70%)
Micro CapUnder $10Healthcare
$3.51
$10.99
$5.14
$6.50
EPS (TTM)$-17.91
P/E Ratio—
Dividend Yield—
Market Cap$72.7M
Volume17.44M
Prev Close$6.66
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$34.1M-$102.2M$-7.00—-299.9%
Q3 '25$44.0M-$33.1M$-3.82—-75.2%
Q2 '25$37.9M-$37.3M$-4.32—-98.2%
Q1 '25$30.0M-$23.5M$-2.77—-78.2%
Q3 '24$38.8M-$32.1M$-0.26—-82.7%
Q2 '24$42.8M$23.8M$-0.20—55.6%
Q1 '24$33.1M-$37.4M$-0.32—-112.8%
Q4 '23$33.7M-$41.8M$-0.36—-124.0%
Get Your Daily Market Recap